State Ledger
Company profile

Instil Bio, Inc. CIK 1789769

Ticker
TIL (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Dallas, TX 75219
Fiscal year end
2025 (FY)
Market Data
Close
$6.72
Change
+$0.21
Change %
3.23%
Volume
493

TIL · trading date Oct 9, 2026 · previous close $6.51 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$71.37M
Total assets
$203.52M
Total liabilities
$89.66M
Stockholders' equity
$113.87M
Cash & equivalents
$6.64M
Operating income
-$78.58M
Operating cash flow
-$36.62M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-27. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
44.1%
Equity / assets
55.9%
CapEx / revenue
—
Operating cash flow / net income
0.51×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$71.37M $203.52M $89.66M $113.87M
2024 — -$74.14M $263.57M $94.13M $169.44M
2023 — -$156.09M $325.63M $99.80M $225.83M
2022 — -$223.18M $482.13M $118.52M $363.61M
2021 $0 -$156.79M $609.98M $54.78M $555.20M
Company Details
SIC code
2836
State of incorporation
NY
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-13
Financials filed via
Form 10-K
filed 2026-03-27

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Dallas, TX 75219
3963 MAPLE AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies